News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
Presentation THT 2024 Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy Presenter: Candice Lee March 06, 2024
Presentation THT 2024 Risk Stratification and Treatment Goals of Acute PE Presenter: Catalin Toma March 06, 2024
Presentation THT 2024 Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics Presenter: Lucas Zier March 06, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024